Cell Biology International
暂无分享,去创建一个
K. Mahnam | A. Doosti | Tabrizi | M. Chaleshtori | P. Soltanzadeh | Tabrizi | Masoumeh Pourhadi | Sayedeh Azimeh Hosseini | Mohammad | Fatemeh Ghanavatinejad | Ameneh Mehri | Zahra Pourteymourfard | Ghahfarrokhi | Saeid Jami | Zahra Pourteymourfard | Ameneh Mehri | Ghahfarrokhi | Mohammad | Saeid Jami
[1] Josep Ramón Goñi,et al. Molecular dynamics simulations: advances and applications , 2015, Advances and applications in bioinformatics and chemistry : AABC.
[2] M. Jami,et al. Differentiation of dental pulp stem cells into neuron-like cells , 2019, The International journal of neuroscience.
[3] M. Jami,et al. Increased levels of miR-124 in human dental pulp stem cells alter the expression of neural markers , 2019, Journal of otology.
[4] M. Jami,et al. Protein biomarkers of neural system , 2019, Journal of otology.
[5] H. Zayed,et al. Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson’s and Gaucher diseases , 2018, Metabolic Brain Disease.
[6] J. Svaren,et al. Myelin protein zero mutations and the unfolded protein response in Charcot Marie Tooth disease type 1B , 2018, Annals of clinical and translational neurology.
[7] M. Jami,et al. Comparison of Three Types of Mesenchymal Stem Cells (Bone Marrow, Adipose Tissue, and Umbilical Cord-Derived) as Potential Sources for Inner Ear Regeneration. , 2017, The international tinnitus journal.
[8] M. Jami,et al. Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress , 2017, Antioxidants.
[9] G. C,et al. Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I , 2017, Metabolic Brain Disease.
[10] M. Jami,et al. MicroRNAs: effective elements in ear-related diseases and hearing loss , 2017, European Archives of Oto-Rhino-Laryngology.
[11] T. Touvier,et al. Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders , 2017, Front. Mol. Neurosci..
[12] G C P van Zundert,et al. The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. , 2016, Journal of molecular biology.
[13] M. Jami,et al. Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress , 2015, Neurochemistry International.
[14] C. George Priya Doss,et al. Impact of I30T and I30M substitution in MPZ gene associated with Dejerine-Sottas syndrome type B (DSSB): A molecular modeling and dynamics. , 2015, Journal of theoretical biology.
[15] K. Mahnam,et al. Improvement of Cd2+ uptake ability of SmtA protein by Lys/Cys mutation; experimental and theoretical studies , 2015, Journal of biomolecular structure & dynamics.
[16] A. Doosti,et al. Comparison between the cultures of human induced pluripotent stem cells (hiPSCs) on feeder-and serum-free system (Matrigel matrix), MEF and HDF feeder cell lines , 2015, Journal of Cell Communication and Signaling.
[17] M. Babst. Quality control at the plasma membrane: One mechanism does not fit all , 2014, The Journal of cell biology.
[18] J. Lupski,et al. The allelic spectrum of Charcot–Marie–Tooth disease in over 17,000 individuals with neuropathy , 2014, Molecular genetics & genomic medicine.
[19] J. Polke,et al. Clinical implications of genetic advances in Charcot–Marie–Tooth disease , 2013, Nature Reviews Neurology.
[20] G. Braathen. Genetic epidemiology of Charcot–Marie–Tooth disease , 2012, Acta neurologica Scandinavica. Supplementum.
[21] A. Madadkar-Sobhani,et al. Characterization of adenosine receptor in its native environment: insights from molecular dynamics simulations of palmitoylated/glycosylated, membrane-integrated human A2B adenosine receptor , 2012, Journal of Molecular Modeling.
[22] J. Kamholz,et al. Crystal structure of the extracellular domain of human myelin protein zero , 2011, Proteins.
[23] G. Lukács,et al. Protein quality control at the plasma membrane. , 2011, Current opinion in cell biology.
[24] M. Russell,et al. Genetic epidemiology of Charcot–Marie–Tooth in the general population , 2011, European journal of neurology.
[25] Tal Pupko,et al. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids , 2010, Nucleic Acids Res..
[26] P. Fossa,et al. Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies , 2009, European Journal of Human Genetics.
[27] E. Carpenter,et al. Overcoming the challenges of membrane protein crystallography , 2008, Current opinion in structural biology.
[28] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[29] Alan Grossfield,et al. Convergence of molecular dynamics simulations of membrane proteins , 2007, Proteins.
[30] U. Suter,et al. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot‐Marie‐Tooth disease) , 2006, Glia.
[31] Richard A Lewis,et al. Phenotypic clustering in MPZ mutations. , 2004, Brain : a journal of neurology.
[32] Berk Hess,et al. GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .
[33] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..
[34] D. van der Spoel,et al. GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .
[35] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[36] Haesun A Kim,et al. Schwann Cells , 2018, Methods in Molecular Biology.
[37] C. Verhamme. Charcot-Marie-Tooth type 1A: natural course, pathophysiology and treatment , 2010 .
[38] U. Suter,et al. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease , 2007, NeuroMolecular Medicine.
[39] D. Kirschner,et al. Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects. , 1996, Journal of neuroscience research.